Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Curagen Corp. (MM) (CRGN)

Curagen Corp. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRGN
DateTimeSourceHeadlineSymbolCompany
02/10/200911:02Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
01/10/200921:28Edgar (US Regulatory)(25-NSE)NASDAQ:CRGNCuragen Corp. (MM)
01/10/200919:29Business WireCelldex Therapeutics Announces Completed Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
30/09/200923:00Business WireCelldex and CuraGen Stockholders Approve Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
25/09/200921:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRGNCuragen Corp. (MM)
25/09/200918:33Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
03/09/200911:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
28/08/200922:27Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:CRGNCuragen Corp. (MM)
17/08/200921:50Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:CRGNCuragen Corp. (MM)
10/08/200916:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRGNCuragen Corp. (MM)
05/08/200919:03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CRGNCuragen Corp. (MM)
31/07/200919:35Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
31/07/200919:33Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
31/07/200911:00PR Newswire (US)CuraGen Reports Second Quarter 2009 Financial ResultsNASDAQ:CRGN
22/06/200922:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:CRGNCuragen Corp. (MM)
19/06/200918:45Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CRGNCuragen Corp. (MM)
18/06/200918:43Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
17/06/200911:30PR Newswire (US)CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast CancerNASDAQ:CRGNCuragen Corp. (MM)
10/06/200922:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CRGNCuragen Corp. (MM)
09/06/200920:22Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:CRGNCuragen Corp. (MM)
03/06/200920:42Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:CRGNCuragen Corp. (MM)
02/06/200911:30PR Newswire (US)CuraGen Updates CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
29/05/200922:26Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
29/05/200922:24Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
29/05/200921:50Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:CRGNCuragen Corp. (MM)
29/05/200921:35Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
29/05/200921:33Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
29/05/200911:54Business WireCelldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
28/05/200911:30PR Newswire (US)CuraGen to Present CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
19/05/200920:15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CRGNCuragen Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:CRGN